about
The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related GenesAssociation of plasma Aß peptides with blood pressure in the elderlyNovel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity.Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population.Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study.Bone mineral density, adiposity, and cognitive functionsFollow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort.Olfactory discrimination predicts cognitive decline among community-dwelling older adults.Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodologyAPOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.The Relationship between Sleep Quality and Brain Amyloid Burden.Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease.Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of agingClinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults.The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men.Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness.Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing.Examination of the current top candidate genes for AD in a genome-wide association study.Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.No association of common VCP variants with sporadic frontotemporal dementia.BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers.Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia.Study protocol of the Intense Physical Activity and Cognition study: The effect of high-intensity exercise training on cognitive function in older adults.Blood-based protein biomarkers for diagnosis of Alzheimer disease.KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden.Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised Medicine.
P50
Q27315066-4BA3D1EB-0C55-4435-8A79-82D8AA1F9C0BQ28740991-D1336082-6F97-41D0-9083-6C737EB3A7D8Q33333767-B00E2315-8BBC-4920-AF6C-276D95A121BEQ33884978-D3E2FB40-A0AD-47B4-9C1B-C930229E658AQ34145734-104D411A-34C6-4AC4-A9BC-1CF56AACF2F5Q35076662-04142AF2-A9B4-4A19-8925-213E80EF1B6DQ35086470-F3729D3F-6B5F-4B85-A49F-A4CD889D6F76Q35094573-D138D35D-7287-46CB-A624-E54944B51730Q35342893-3684C09B-64FA-41D4-AA8F-5767E9700CE5Q36001600-01ECCADD-F42A-443B-AC0C-120A01048FA2Q36298550-5C5F1432-6F58-41CD-9EC4-714EEE93AEDFQ36594552-6E7E9D20-0223-406C-9F41-83C9C9433122Q36808756-2C55C3F4-380F-48C2-8768-000B4C9A269EQ36882004-366DE1EE-64FF-4395-A9D8-A657A8E87FCFQ36934171-72889783-0907-49B4-96A8-415F5DB09344Q38378624-D128B830-FA8A-45D1-B30E-F6EB9378FE55Q38603015-DD01A3EC-2C88-4EF0-A746-E0633FA9657BQ38797404-71CEE5AC-A327-4E8B-96A5-DCBB78C5FE89Q38944065-EBB98731-F0CC-4C31-8214-483D98FDE819Q39290022-CBE5AC02-8F2F-48A8-A407-3A019FD77C47Q39876660-14BE605F-0348-4A8C-933F-BE633EA70DF8Q39880236-E9E8F2A4-5C5C-4CCC-9B65-DE8C1FC16CF1Q40316441-2D20D678-A8CB-4963-8829-FC39707B5D57Q40722405-9FA66316-A000-4773-AABA-3E813FB2C056Q41084541-D89395B3-AEB1-46E9-A422-D9DBB1533622Q41587731-6333759B-5A1C-49E1-BFCC-87673DB89992Q44031576-41B6D695-F7CE-4899-BEB6-9AC99175D4A6Q44137053-76E931DF-8943-438D-8156-896378207DECQ44586222-9E74CB04-329B-43DA-81B6-C354809A2203Q45199554-8AFF7BC3-1660-499E-A3C9-31CD3E8F7D9FQ45356235-3EA97EAB-2DCE-4301-9F7D-94F42A508561Q46052727-23E39BB9-5648-4781-B944-0304F5C82817Q46254853-B3C83944-7122-4C5F-824D-2590FCC367F8Q46397777-CEFB0C11-F426-49E6-B969-2462E5B48CAFQ46979841-D42D4F02-0EA2-48A1-A503-78A6BBC2B181Q47164824-9C6AF8C1-2BC2-427D-A6AD-208BC13AD3E9Q47378944-6F5BC304-CB54-4471-9581-A7CAC1C34DFDQ47549663-DE602F31-4648-4A7C-9689-D7E94FDD41C9Q47550446-E1FA3C0D-F8DE-43B8-AD6D-8428BEA0B1C3Q47550646-43D0DD71-7CC2-4D7D-947D-BA8003AA579B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Simon M Laws
@es
Simon M Laws
@nl
Simon M Laws
@sl
Simon M. Laws
@en
type
label
Simon M Laws
@es
Simon M Laws
@nl
Simon M Laws
@sl
Simon M. Laws
@en
prefLabel
Simon M Laws
@es
Simon M Laws
@nl
Simon M Laws
@sl
Simon M. Laws
@en
P1053
C-2858-2014
P106
P1153
7004558817
P21
P31
P3829
P496
0000-0002-4355-7082